期刊文献+

贝那普利治疗心力衰竭60例临床分析 被引量:2

Benazepril for Heart Failure: A Clinical Analysis of 60 Cases
下载PDF
导出
摘要 目的探讨贝那普利治疗心力衰竭的疗效。方法 120例心衰患者随机分为观察组和对照组,观察组给予常规基础治疗加贝那普利,对照组给予常规基础治疗加安慰剂,分析两组的疗效。结果观察组治疗后的显效率、有效率明显高于对照组,无效率明显低于对照组,两组比较具有统计学意义(P<0.05)。观察组的总有效率为91.7%,对照组的总有效率为50%,两组比较是有统计学意义(P<0.05)。结论贝那普利对治疗心衰有肯定的疗效,具有较好的临床使用价值。 Objective To investigate the efficacy of Benazeprilin in the treatment of heart failure. Methods We divided 120 cases of heart failure randomly into two groups, observation group and control group. The observation group received conventional treatment plus benazepril and the control group was given conventional therapy plus placebo. And the efficacy of the two groups was analyzed. Results The markedly effective rate and the effective rate were significantly higher and the inefficiency was lower in the observation group after treatment than those in the control group, with a significant difference between the two groups (P〈0.05). The total effective rate of the observation group was 91.7% and that of the control group was 50%, with a significant difference between the two groups (P〈0.05). Conclusion Benazepril has a positive effect on heart failure, with a good clinical value.
出处 《中国现代医生》 2010年第21期50-50,54,共2页 China Modern Doctor
关键词 贝那普利 心力衰竭 疗效 Benazepril Heart failure Efficacy
  • 相关文献

参考文献3

二级参考文献15

  • 1胡大一,吴彦.规范心力衰竭治疗 加强患者管理[J].中华心血管病杂志,2005,33(6):495-497. 被引量:124
  • 2[3]Cohn JN.The prevention 0f heart failure-A new agenda.N Engl J Med,1992,327(10):725-727.
  • 3[5]Love MP,Me Murray JJV.Endothelin in congestive heart failure[J].Basic Res Cardiol,1996,91(Suppll):21-29.
  • 4Stewart S, Maclntyre K, Macleod MM, et al. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? Eur Heart J,2001, 22:209-217.
  • 5Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J,2001,22:1527-1560.
  • 6Felker GM, Adams KF Jr, Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J,2003,145:S18-S25.
  • 7Berry C, Murdoch DR, McMurray JJ. Economics of chronic heart failure. Eur J Heart Fail,2001,3:283-291.
  • 8Coletta AP, Cleland JG, Freemantle N, et al. Clinical trials update from the European Society of Cardiology: CHARM, BASEL, EUROPA and ESTEEM. Eur J Heart Fail,2003,5:697-704.
  • 9Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators.Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005, 352:225-237.
  • 10Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med, 2005,352:1539-1549.

共引文献128

同被引文献13

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部